Moreover, Pai and collaborators proved that the expression of another barrier molecule, the desmosomal protein dystonin, was inversely correlated with the Th1-like immune signature in patients with metastatic melanoma and ovarian cancer (45), and was associated with worse prognosis in patients with melanoma (103). This evidence concerns the gene DST and melanoma.